Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Simulations Plus, Inc.

Market Cap 369M 321M 298M 279M 522M 34.78B 526M 3.53B 1.37B 17.12B 1.38B 1.35B 59.43B P/E 2026 *
43.7x
P/E 2027 * 40.3x
Enterprise Value 369M 321M 298M 279M 522M 34.78B 526M 3.53B 1.37B 17.12B 1.38B 1.35B 59.43B EV / Sales 2026 *
4.51x
EV / Sales 2027 * 4.28x
Free-Float
82.79%
Yield 2026 *
-
Yield 2027 * -
1 day-0.05%
1 week+11.76%
Current month+6.60%
1 month+26.05%
3 months+56.30%
6 months-2.72%
Current year+0.05%
1 week 16.28
Extreme 16.28
18.56
1 month 15.13
Extreme 15.13
18.56
Current year 11.09
Extreme 11.09
21.01
1 year 11.09
Extreme 11.09
21.01
3 years 11.09
Extreme 11.09
52.69
5 years 11.09
Extreme 11.09
67.59
10 years 6.74
Extreme 6.74
90.92
Manager TitleAgeSince
Chief Executive Officer 67 25/06/2018
Director of Finance/CFO 63 30/11/2020
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 81 16/07/1996
Director/Board Member 58 02/12/2014
Chairman 76 16/12/2024
Date Insider Type Main position Quantity % Market Cap.
06-15Fiscal year

Executive/Senior Manager

22,050 0.1094%
06-14Fiscal year

Executive/Senior Manager

3,150 0.0156%
06-02Sell

Executive/Senior Manager

-1,000 0.0050%
Change 5-day change 1-year change 3-year change Capi.($)
-0.05%+11.76%+5.25%-60.90% 369M
-1.00%-3.91%-45.27%-24.25% 24.9B
+3.10%+5.37%-37.57%+147.53% 12.66B
-2.54%-8.34%-11.79%+51.17% 5.57B
+2.44%+1.20% - - 2.9B
+4.47%+17.04% - - 1.86B
+1.43%+3.22%+39.32%-46.78% 1.78B
+2.47%+1.73%-18.56% - 1.31B
-0.29%-2.54%-31.62%-62.23% 792M
-1.14%-5.54%-33.86%+223.48% 744M
Average +0.89%+2.65%-16.76%+32.58% 5.29B
Weighted average by Cap. +0.38%-0.84%-34.73%+33.33%

Financials

2026 *2027 *
Net sales 81.71M 71.24M 65.98M 61.76M 116M 7.71B 117M 783M 303M 3.79B 307M 300M 13.18B 86.2M 75.15M 69.61M 65.16M 122M 8.13B 123M 826M 320M 4B 324M 317M 13.9B
Net income 9.02M 7.87M 7.29M 6.82M 12.79M 851M 12.87M 86.43M 33.5M 419M 33.87M 33.14M 1.46B 9.71M 8.47M 7.84M 7.34M 13.76M 916M 13.85M 93.01M 36.05M 451M 36.45M 35.66M 1.57B
Net Debt - -
Logo Simulations Plus, Inc.
Simulations Plus, Inc. specializes in model-informed and artificial intelligence (AI)-accelerated drug development. The Company helps its clients by accelerating the discovery, development, and commercialization of pharmaceuticals and other products through science-based software and consulting solutions. The Company’s segments include Software and Services. The Company's Software segment supports pharmaceutical research, development, and commercialization through simulation, modeling, and AI-driven prediction. Its main products include GastroPlus, ADMET Predictor, MonolixSuite, and others for disease modeling and training, as well as Pro-ficiency for clinical operations. Its Services segment includes advanced consulting services across the entire drug development lifecycle. Its scientists and engineers specialize in drug discovery, pharmacokinetics, pharmacodynamics, drug modeling, clinical trial data analysis, regulatory strategy, and medical communications.
Employees
213
Date Price Change Volume
18/06/26 18.24 $ -0.05% 1,045,413
17/06/26 18.25 $ +0.05% 1,429,029
16/06/26 18.24 $ +11.42% 2,174,619
15/06/26 16.37 $ +0.31% 177,999
12/06/26 16.32 $ -1.03% 160,725
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
5
Last Close Price
18.24USD
Average target price
17.25USD
Spread / Average Target
-5.43%

Quarterly revenue - Rate of surprise

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!